IL203744A - Amino phenyl acid compound, preparations containing it and its use - Google Patents
Amino phenyl acid compound, preparations containing it and its useInfo
- Publication number
- IL203744A IL203744A IL203744A IL20374410A IL203744A IL 203744 A IL203744 A IL 203744A IL 203744 A IL203744 A IL 203744A IL 20374410 A IL20374410 A IL 20374410A IL 203744 A IL203744 A IL 203744A
- Authority
- IL
- Israel
- Prior art keywords
- optionally oxidized
- compositions
- same
- alkyl group
- acid compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Child & Adolescent Psychology (AREA)
- Vascular Medicine (AREA)
- Virology (AREA)
- Anesthesiology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007208815 | 2007-08-10 | ||
| PCT/JP2008/064429 WO2009022687A1 (fr) | 2007-08-10 | 2008-08-11 | Composé d'acide phénylacétique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL203744A true IL203744A (en) | 2013-09-30 |
Family
ID=40350739
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL203744A IL203744A (en) | 2007-08-10 | 2010-02-04 | Amino phenyl acid compound, preparations containing it and its use |
Country Status (20)
| Country | Link |
|---|---|
| US (4) | US8318729B2 (fr) |
| EP (1) | EP2177513B1 (fr) |
| JP (2) | JP5083319B2 (fr) |
| KR (1) | KR101464799B1 (fr) |
| CN (1) | CN101796039B (fr) |
| AU (1) | AU2008287784B2 (fr) |
| BR (1) | BRPI0815332A2 (fr) |
| CA (1) | CA2695757C (fr) |
| DK (1) | DK2177513T3 (fr) |
| ES (1) | ES2543970T3 (fr) |
| HU (1) | HUE027706T2 (fr) |
| IL (1) | IL203744A (fr) |
| MX (1) | MX2010001344A (fr) |
| NZ (1) | NZ583032A (fr) |
| PL (1) | PL2177513T3 (fr) |
| PT (1) | PT2177513E (fr) |
| RU (1) | RU2470926C2 (fr) |
| TW (1) | TWI410410B (fr) |
| WO (1) | WO2009022687A1 (fr) |
| ZA (1) | ZA201000869B (fr) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI410410B (zh) | 2007-08-10 | 2013-10-01 | Ono Pharmaceutical Co | Phenylacetic acid compounds |
| CN102348982B (zh) * | 2009-03-09 | 2014-09-17 | 公益财团法人大阪生物科学研究所 | 肌变性疾病的检测方法以及治疗效果判定方法 |
| EP2986301A4 (fr) * | 2013-04-19 | 2016-09-14 | Cedars Sinai Medical Center | Inhibiteurs de phosphodiestérase 5a pour le traitement de dystrophie musculaire |
| RU2577697C2 (ru) * | 2014-12-26 | 2016-03-20 | Анатолий Тимофеевич Корабельников | Средство для избавления от полипов в пазухах носа и для предотвращения их повторного нарастания, а также способ его применения |
| RU2611374C1 (ru) * | 2015-11-02 | 2017-02-21 | Анатолий Тимофеевич Корабельников | Средство для избавления от полипов в пазухах носа и для предотвращения их повторного нарастания, а также способ его применения |
| RU2626829C2 (ru) * | 2015-11-02 | 2017-08-02 | Анатолий Тимофеевич Корабельников | Средство для лечения полипов в пазухах носа и для предотвращения их повторного нарастания, а также способ его применения |
| RU2647374C1 (ru) * | 2017-07-19 | 2018-03-15 | федеральное государственное бюджетное образовательное учреждение высшего образования "Тверской государственный медицинский университет" Министерства здравоохранения Российской Федерации | Способ профилактики анафилактического шока при введении гетерологических сывороток |
| EP3854781B1 (fr) * | 2018-09-20 | 2024-05-22 | ONO Pharmaceutical Co., Ltd. | Antagonistes de dp |
| JP7047954B2 (ja) * | 2020-03-19 | 2022-04-05 | 小野薬品工業株式会社 | フェニル酢酸化合物を含有する医薬組成物 |
| WO2021187547A1 (fr) * | 2020-03-19 | 2021-09-23 | 小野薬品工業株式会社 | Cristal de composé de phénylacétate |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0218728A1 (fr) | 1985-04-03 | 1987-04-22 | Yamanouchi Pharmaceutical Co. Ltd. | Derives d'phenylene |
| US5696117A (en) | 1995-11-07 | 1997-12-09 | Ortho Pharmaceutical Corporation | Benzoxazine antimicrobial agents |
| ES2181039T3 (es) | 1996-12-13 | 2003-02-16 | Shionogi & Co | Derivados de benzotiofenocarboxamida y antagonistas de pgd2 que los comprenden. |
| KR20030010589A (ko) | 2000-03-09 | 2003-02-05 | 오노 야꾸힝 고교 가부시키가이샤 | 인돌 유도체, 그 제조 방법 및 용도 |
| CA2452953A1 (fr) * | 2001-07-18 | 2003-01-30 | The Research Foundation Of State University Of New York | Endoprothese pour dispositif et procede d'intervention vasculaire |
| WO2003078409A1 (fr) * | 2002-03-19 | 2003-09-25 | Ono Pharmaceutical Co., Ltd. | Composes d'acide carboxylique et medicaments renfermant les composes comme principe actif |
| KR20060080197A (ko) * | 2003-09-17 | 2006-07-07 | 오노 야꾸힝 고교 가부시키가이샤 | 카르복실산 화합물 및 이들을 유효 성분으로서 함유하는의약 조성물 |
| TWI410410B (zh) * | 2007-08-10 | 2013-10-01 | Ono Pharmaceutical Co | Phenylacetic acid compounds |
-
2008
- 2008-08-08 TW TW097130454A patent/TWI410410B/zh not_active IP Right Cessation
- 2008-08-11 PL PL08827402T patent/PL2177513T3/pl unknown
- 2008-08-11 PT PT88274022T patent/PT2177513E/pt unknown
- 2008-08-11 HU HUE08827402A patent/HUE027706T2/en unknown
- 2008-08-11 CN CN2008801028454A patent/CN101796039B/zh not_active Expired - Fee Related
- 2008-08-11 DK DK08827402.2T patent/DK2177513T3/en active
- 2008-08-11 RU RU2010108470/04A patent/RU2470926C2/ru not_active IP Right Cessation
- 2008-08-11 CA CA2695757A patent/CA2695757C/fr active Active
- 2008-08-11 BR BRPI0815332-9A2A patent/BRPI0815332A2/pt not_active Application Discontinuation
- 2008-08-11 AU AU2008287784A patent/AU2008287784B2/en not_active Ceased
- 2008-08-11 WO PCT/JP2008/064429 patent/WO2009022687A1/fr active Application Filing
- 2008-08-11 ES ES08827402.2T patent/ES2543970T3/es active Active
- 2008-08-11 EP EP08827402.2A patent/EP2177513B1/fr not_active Not-in-force
- 2008-08-11 MX MX2010001344A patent/MX2010001344A/es active IP Right Grant
- 2008-08-11 JP JP2009528131A patent/JP5083319B2/ja active Active
- 2008-08-11 KR KR1020107002765A patent/KR101464799B1/ko not_active IP Right Cessation
- 2008-08-11 US US12/672,762 patent/US8318729B2/en active Active
- 2008-08-11 NZ NZ583032A patent/NZ583032A/en not_active IP Right Cessation
-
2010
- 2010-02-04 IL IL203744A patent/IL203744A/en not_active IP Right Cessation
- 2010-02-05 ZA ZA2010/00869A patent/ZA201000869B/en unknown
-
2012
- 2012-07-12 JP JP2012156734A patent/JP5655822B2/ja not_active Expired - Fee Related
- 2012-09-26 US US13/627,720 patent/US8476266B2/en not_active Expired - Fee Related
-
2013
- 2013-04-01 US US13/854,329 patent/US8809524B2/en active Active
-
2014
- 2014-08-15 US US14/460,391 patent/US20140357630A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL203744A (en) | Amino phenyl acid compound, preparations containing it and its use | |
| IL204621A (en) | Amino Acid Derivatives - γ - In bicycles preparations containing them and their uses | |
| MX2007009660A (es) | Concentrado lubricante que contiene fosfato-triester. | |
| TN2009000024A1 (en) | Prodrug of cinnamide compound | |
| MX2011009354A (es) | Compuesto de piridazinona y su uso. | |
| WO2008140099A1 (fr) | Dérivés de tétrazoyl-oxime et agent de lutte contre une maladie végétale | |
| EP1953154A4 (fr) | Composes cinnamide de type morpholine | |
| WO2008126933A3 (fr) | Procédé de production de composé amide | |
| ATE545665T1 (de) | Nitrilgruppen enthaltendes polymer und verfahren zu seiner synthetisierung, zusammensetzung mit nitrilgruppen enthaltendem polymer und laminat | |
| WO2008146871A1 (fr) | Nouveau dérivé de 1,2,3,4-tétrahydroquinoxaline qui a, comme substituant, un groupe phényle dans lequel est introduite une structure d'ester d'acide sulfonique ou une structure d'amide d'acide sulfonique et qui possède une activité de liaison aux récepteurs des glucocorticoïdes | |
| WO2008108378A3 (fr) | Dérivé bicyclique d'oxomorpholine | |
| TW200744659A (en) | Preparation for preventing and ameliorating wrinkle | |
| TW200600971A (en) | Calixresorcinarene compounds, photoresist base materials, and compositions thereof | |
| ATE500212T1 (de) | Bisphenol monoester | |
| WO2007033764A3 (fr) | Compositions biocides | |
| WO2008081852A1 (fr) | Composition et élément électroluminescent comprenant la composition | |
| WO2009069296A1 (fr) | Agent d'élimination d'un biolfilm | |
| SG168499A1 (en) | New dihydroindolone compounds, a process for their preparation and pharmaceutical compositions containing them | |
| WO2010017925A3 (fr) | Association herbicide-phytoprotecteur composée d'anilides de difluorométhanesulfonyle à substitution diméthoxytriazinyle | |
| EP2578617A4 (fr) | Composé de polyamide | |
| IN2015KN00276A (fr) | ||
| WO2007122792A3 (fr) | Composition inhibitrice de formation de biofilm | |
| WO2008117871A1 (fr) | Catalyseur redox contenant de l'azote | |
| WO2008090717A1 (fr) | Inhibiteur de l'adam | |
| MX2022002898A (es) | Compuesto de 7-oxa-3,4-diazabiciclo-[4.1.0]-4-hepten-2-ona y herbicida. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |